{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:18:46Z","timestamp":1789615126929,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Major Scientific and Technological Special Project for Significant New Drugs Development","award":["2013ZX09102030"],"award-info":[{"award-number":["2013ZX09102030"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.intimp.2019.01.055","type":"journal-article","created":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T04:00:34Z","timestamp":1550289634000},"page":"389-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Hydrogen peroxide-inactivated bacteria induces potent humoral and cellular immune responses and releases nucleic acids"],"prefix":"10.1016","volume":"69","author":[{"given":"Yingzi","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandong","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaomei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.01.055_bb0005","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4161\/hv.7.10.16369","article-title":"Recent developments for Pseudomonas vaccines","volume":"7","author":"Sharma","year":"2011","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.intimp.2019.01.055_bb0010","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/IAI.74.2.968-974.2006","article-title":"Safety and immunogenicity of an oral inactivated whole-cell Pseudomonas aeruginosa vaccine administered to healthy human subjects","volume":"74","author":"Cripps","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2019.01.055_bb0015","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/cid\/cis033","article-title":"Challenges for a universal Staphylococcus aureus vaccine","volume":"54","author":"Proctor","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2019.01.055_bb0020","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.vaccine.2014.03.078","article-title":"How advances in immunology provide insight into improving vaccine efficacy","volume":"32","author":"Slifka","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2019.01.055_bb0025","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1128\/AAC.02823-14","article-title":"In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method","volume":"58","author":"Wu","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2019.01.055_bb0030","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.2147\/IJN.S91529","article-title":"Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine","volume":"10","author":"sun","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2019.01.055_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2018.05.083","article-title":"Long-lived and short-lived reactive species produced by a cold atmospheric pressure plasma jet for the inactivation of Pseudomonas aeruginosa and Staphylococcus aureus","volume":"124","author":"Santosh","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2019.01.055_bb0040","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/nm.2763","article-title":"Development of a new hydrogen peroxide\u2013based vaccine platform","volume":"18","author":"Amanna","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2019.01.055_bb0045","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/JVI.02903-12","article-title":"A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice","volume":"87","author":"Pinto","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2019.01.055_bb0050","doi-asserted-by":"crossref","first-page":"13735","DOI":"10.1128\/JVI.02178-12","article-title":"Characterization of CD8+ T cell function and immunodominance generated with an H2O2-inactivated whole-virus vaccine","volume":"86","author":"Walker","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2019.01.055_bb0055","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s13104-015-1329-z","article-title":"Disinfection by hydrogen peroxide nebulization increases susceptibility to avian pathogenic Escherichia coli","volume":"8","author":"Oosterik","year":"2015","journal-title":"BMC. Res. Notes"},{"key":"10.1016\/j.intimp.2019.01.055_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftv067","article-title":"Roads to the development of improved pertussis vaccines paved by immunology","volume":"73","author":"Brummelman","year":"2015","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.intimp.2019.01.055_bb0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nri.2016.63","article-title":"Innate sensing of oxidation-specific epitopes in health and disease","volume":"16","author":"Binder","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.01.055_bb0070","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/IAI.49.2.281-285.1985","article-title":"Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide","volume":"49","author":"Ames","year":"1985","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2019.01.055_bb0075","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1128\/IAI.62.9.3608-3616.1994","article-title":"Immunogenic and antigenic properties of a heptavalent high molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa","volume":"62","author":"Hatano","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2019.01.055_bb0080","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.71.3.1453-1461.2003","article-title":"Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant infect","volume":"71","author":"Priebe","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2019.01.055_bb0085","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1084\/jem.20100995","article-title":"A requirement for Fc\u03b3R in antibody mediated bacterial toxin neutralization","volume":"207","author":"Abboud","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2019.01.055_bb0090","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2249.2005.02925.x","article-title":"Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine","volume":"142","author":"Zuercher","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2019.01.055_bb0095","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen","volume":"160","author":"Davis","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.01.055_bb0100","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/infdis\/jis416","article-title":"Protection against Clostridium difficile infection with broadly neutralizing antitoxin monoclonal antibodies","volume":"206","author":"Marozsan","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2019.01.055_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijmm.2007.03.012","article-title":"Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity","volume":"297","author":"Pier","year":"2007","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.intimp.2019.01.055_bb0110","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1016\/j.vaccine.2009.07.108","article-title":"Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin","volume":"27","author":"Cheng","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2019.01.055_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041501","article-title":"Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine","volume":"7","author":"Weldon","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2019.01.055_bb0120","article-title":"Enhancing specific-antibody production to the ragB vaccine with GITRL that expand Tfh, IFN-\u03b3+ T cells and attenuates Porphyromonas gingivalis infection in mice","volume":"8","author":"Zheng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2019.01.055_bb0125","article-title":"NADPH phagocyte oxidase knockout mice control trypanosoma cruzi proliferation, but develop circulatory collapse and succumb to infection","volume":"7","author":"Santiago","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2019.01.055_bb0130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1172\/JCI72676","article-title":"Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity","volume":"124","author":"Bournazos","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2019.01.055_bb0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor toll stimulation led to enhanced RSV disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2019.01.055_bb0150","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nri2849","article-title":"The importance of natural IgM: scavenger, protector and regulator","volume":"10","author":"Ehrenstein","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.01.055_bb0155","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.4049\/jimmunol.181.7.4965","article-title":"IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa","volume":"181","author":"Priebe","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.01.055_bb0160","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1128\/IAI.70.3.1507-1517.2002","article-title":"Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine","volume":"70","author":"Priebe","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2019.01.055_bb0165","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1128\/IAI.72.12.7012-7021.2004","article-title":"Oral vaccination of BALB\/c mice with Salmonella enterica Serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model","volume":"72","author":"DiGiandomenico","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2019.01.055_bb0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2009.06.003","article-title":"IgM in microbial infections: taken for granted","volume":"125","author":"Racine","year":"2009","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2019.01.055_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/srep33094","article-title":"The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria","volume":"6","author":"Weaver","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2019.01.055_bb0180","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.immuni.2011.05.009","article-title":"Host defence pathways: role of redundancy and compensation in infectious disease phenotypes","volume":"34","author":"Nish","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2019.01.055_bb0185","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/IAI.01139-10","article-title":"Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection","volume":"79","author":"Kamei","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2019.01.055_bb0190","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/IAI.06348-11","article-title":"Neutralizing antibodies elicited by a novel detoxified Pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury","volume":"80","author":"Salha","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2019.01.055_bb0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.2041-1014.2009.00560.x","article-title":"Oral immunization with Porphyromonas gingivalis outer membrane protein and CpG oligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity","volume":"25","author":"Liu","year":"2010","journal-title":"Mol Oral Microbiol"},{"key":"10.1016\/j.intimp.2019.01.055_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2012.00168","article-title":"Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination","volume":"2","author":"Jounai","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2019.01.055_bb0205","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nm.2403","article-title":"DNA released from dying host cells mediates aluminum adjuvant activity","volume":"17","author":"Marichal","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2019.01.055_bb0210","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1128\/JB.00906-09","article-title":"Characterization of hydrogen peroxide-induced DNA release by Streptococcus sanguinis and Streptococcus gordonii","volume":"191","author":"Kreth","year":"2009","journal-title":"J. Bacteriol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919302413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919302413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:56:30Z","timestamp":1694627790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919302413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":40,"alternative-id":["S1567576919302413"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.01.055","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogen peroxide-inactivated bacteria induces potent humoral and cellular immune responses and releases nucleic acids","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.01.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}